• LAST PRICE
    15.9100
  • TODAY'S CHANGE (%)
    Trending Down-0.0800 (-0.5003%)
  • Bid / Lots
    15.2600/ 1
  • Ask / Lots
    16.0800/ 1
  • Open / Previous Close
    15.9300 / 15.9900
  • Day Range
    Low 15.7400
    High 15.9500
  • 52 Week Range
    Low 12.2200
    High 16.8650
  • Volume
    338,237
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 15.99
TimeVolumeINVA
09:32 ET180215.92
09:34 ET120015.87
09:36 ET160015.915
09:38 ET10015.915
09:39 ET30015.935
09:43 ET20015.92
09:45 ET40015.88
09:50 ET10015.87
09:54 ET60015.83
09:56 ET79115.855
09:57 ET10015.855
09:59 ET10015.87
10:01 ET10015.87
10:03 ET30015.87
10:08 ET20015.845
10:12 ET20015.85
10:14 ET10015.86
10:15 ET102015.86
10:17 ET12015.87
10:21 ET60015.86
10:24 ET20015.86
10:28 ET70015.875
10:30 ET39015.87
10:32 ET10015.87
10:33 ET10015.865
10:35 ET60015.865
10:37 ET10015.86
10:42 ET50015.865
10:48 ET20015.87
10:50 ET10015.87
10:51 ET20015.87
10:53 ET30015.865
10:57 ET59515.875
11:00 ET20015.88
11:02 ET20015.89
11:15 ET10015.905
11:20 ET10015.905
11:24 ET127015.905
11:27 ET163915.93
11:33 ET34015.93
11:38 ET64815.92
11:42 ET50015.895
11:44 ET43215.89
11:54 ET10015.875
11:56 ET10015.875
11:58 ET30015.875
12:00 ET130915.87
12:02 ET10015.875
12:03 ET81715.87
12:05 ET10015.86
12:09 ET86615.87
12:12 ET40015.895
12:14 ET60015.89
12:16 ET72415.88
12:18 ET10015.85
12:21 ET71215.835
12:23 ET20015.83
12:25 ET10015.84
12:27 ET26415.8307
12:30 ET10015.83
12:32 ET20015.845
12:39 ET10015.845
12:41 ET42815.845
12:43 ET10015.845
12:45 ET10015.845
12:48 ET162115.825
12:52 ET95515.83
12:54 ET70415.835
12:56 ET70015.83
12:57 ET10015.84
01:01 ET52115.83
01:08 ET50015.84
01:10 ET10015.845
01:12 ET20015.84
01:14 ET98415.84
01:15 ET77615.84
01:19 ET51415.82
01:24 ET102115.81
01:26 ET130015.82
01:30 ET20015.825
01:33 ET20015.83
01:35 ET10015.83
01:42 ET70015.815
01:44 ET100015.82
01:46 ET10015.82
01:50 ET24915.82
01:55 ET55515.8
01:57 ET22715.79
02:00 ET30015.79
02:04 ET20015.78
02:08 ET40015.78
02:09 ET31915.78
02:11 ET20015.77
02:13 ET40015.775
02:15 ET30015.775
02:20 ET337415.785
02:24 ET10015.785
02:27 ET110015.775
02:29 ET10015.775
02:31 ET127915.77
02:33 ET99015.76
02:36 ET40015.76
02:40 ET11815.755
02:45 ET100015.75
02:54 ET20015.75
02:56 ET12315.75
02:58 ET260015.78
03:02 ET109015.77
03:03 ET10015.765
03:05 ET50415.765
03:07 ET30015.765
03:09 ET30015.765
03:12 ET54715.76
03:14 ET10015.765
03:16 ET70015.765
03:18 ET315115.78
03:20 ET40015.765
03:21 ET291915.75
03:23 ET70015.765
03:25 ET60015.765
03:27 ET60015.765
03:30 ET20015.77
03:32 ET80015.78
03:34 ET231515.78
03:36 ET509515.79
03:38 ET297515.81
03:39 ET342215.82
03:41 ET263515.815
03:43 ET626715.835
03:45 ET50015.84
03:48 ET531815.83
03:50 ET91615.83
03:52 ET311315.865
03:54 ET701315.855
03:56 ET1237915.9
03:57 ET731015.905
03:59 ET902715.91
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesINVA
Innoviva Inc
993.5M
7.3x
-9.89%
United StatesEOLS
Evolus Inc
709.4M
-10.8x
---
United StatesPROC
Procaps Group SA
293.3M
5.0x
---
United StatesIMCR
Immunocore Holdings PLC
1.9B
-32.1x
---
United StatesANIP
ANI Pharmaceuticals Inc
1.3B
39.3x
-8.16%
United StatesCNBI
China BCT Pharmacy Group Inc
3.8K
0.0x
---
As of 2024-06-15

Company Information

Innoviva, Inc. is a diversified holding company with a portfolio of royalties and other healthcare assets. The Company's royalty portfolio consists of respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI) and ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI). Under the Long-Acting Beta2 Agonist (LABA) Collaboration Agreement, the Company is entitled to receive royalties from GSK on sales of RELVAR/BREO ELLIPTA. The Company's products include GIAPREZA and XERAVA. GIAPREZA (angiotensin II) injection is approved by the United States Food and Drug Administration (FDA) as a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. XERAV (eravacycline) for injection is approved by the United States FDA and Singapore Health Sciences Authority (HSA) as a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections (cIAI).

Contact Information

Headquarters
1350 OLD BAYSHORE HIGHWAY, SUITE 400BURLINGAME, CA, United States 94010
Phone
650-238-9600
Fax
302-655-5049

Executives

Chairman of the Board
Mark Dipaolo
Chief Executive Officer
Pavel Raifeld
Chief Financial Officer
Stephen Basso
Chief Accounting Officer
Marianne Zhen
Lead Independent Director
Sarah Schlesinger

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$993.5M
Revenue (TTM)
$311.6M
Shares Outstanding
62.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.57
EPS
$2.19
Book Value
$10.66
P/E Ratio
7.3x
Price/Sales (TTM)
3.2
Price/Cash Flow (TTM)
4.5x
Operating Margin
35.24%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.